Home
Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/10/03
Trade details
- Type
- Insider sale
- Amount
- $974,670.45
- Shares · price
- 14,235 sh · $68.47 a share
- Held after
- 739,484 sh
- Trade date
- 25/10/03
- Filed
- 25/10/03
- Days to filing
- 0 days
Sold 1.9% of holdings
- Share of holding sold
- 1.9%
Halozyme Therapeutics trades, last 26 weeks
What else happened in Halozyme Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/03~25/11/02Helen Torley's recent trades
- Helen Torley
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 planHalozyme Therapeutics
HALO
$23.7M
240,000 sh
$23.7M
Filed 08/17
Traded 08/17
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$425.1K
6,100 sh
$425.1K
Filed 06/03
Traded 06/03
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01